CLINICAL TRIALS PROFILE FOR CITALOPRAM HYDROBROMIDE
✉ Email this page to a colleague
All Clinical Trials for Citalopram Hydrobromide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00086645 ↗ | Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) | Completed | National Institute of Mental Health (NIMH) | Phase 2 | 2004-04-01 | This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism. |
| NCT00086645 ↗ | Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) | Completed | Boston University | Phase 2 | 2004-04-01 | This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism. |
| NCT00222820 ↗ | Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study | Completed | Mental Health Intervention Research Center (MHIRC) | Phase 4 | 2002-04-01 | We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person's personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication |
| NCT00222820 ↗ | Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study | Completed | University of Pittsburgh | Phase 4 | 2002-04-01 | We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person's personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication |
| NCT00363909 ↗ | Citalopram in Treating Postmenopausal Women With Hot Flashes | Completed | National Cancer Institute (NCI) | Phase 3 | 2006-11-01 | RATIONALE: Citalopram may help relieve hot flashes in women who had or have not had breast cancer. It is not yet known which dose of citalopram is more effective in treating hot flashes in postmenopausal women. PURPOSE: This randomized phase III trial is studying three different doses of citalopram to compare how well they work in treating postmenopausal women with hot flashes. |
| NCT00363909 ↗ | Citalopram in Treating Postmenopausal Women With Hot Flashes | Completed | Alliance for Clinical Trials in Oncology | Phase 3 | 2006-11-01 | RATIONALE: Citalopram may help relieve hot flashes in women who had or have not had breast cancer. It is not yet known which dose of citalopram is more effective in treating hot flashes in postmenopausal women. PURPOSE: This randomized phase III trial is studying three different doses of citalopram to compare how well they work in treating postmenopausal women with hot flashes. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Citalopram Hydrobromide
Condition Name
Clinical Trial Locations for Citalopram Hydrobromide
Trials by Country
Clinical Trial Progress for Citalopram Hydrobromide
Clinical Trial Phase
Clinical Trial Sponsors for Citalopram Hydrobromide
Sponsor Name
